|
NL254871A
(enExample)
|
1959-08-14 |
|
|
|
|
US3939169A
(en)
*
|
1971-03-29 |
1976-02-17 |
Imperial Chemical Industries Limited |
Alkylene bis(pyridiniumareylene quaternary salts)
|
|
GB1339764A
(en)
|
1971-03-29 |
1973-12-05 |
Ici Ltd |
Pyridine derivatives
|
|
DE2942930A1
(de)
|
1979-10-24 |
1981-05-27 |
Basf Ag, 6700 Ludwigshafen |
Substituierte harnstoffe, deren herstellung und verwendung als herbizide
|
|
EP0081142B1
(de)
|
1981-12-03 |
1986-06-25 |
BASF Aktiengesellschaft |
1,3,5-Triazinone, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses
|
|
DE3147879A1
(de)
|
1981-12-03 |
1983-06-16 |
Basf Ag, 6700 Ludwigshafen |
1,3,5-triazinone, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
|
DE3478110D1
(en)
|
1983-03-29 |
1989-06-15 |
Fmc Corp |
N-phenyl-n'-(pyridinyl-n-oxide)urea plant regulators
|
|
US4787931A
(en)
|
1984-03-06 |
1988-11-29 |
Fmc Corporation |
N-phenyl-N'-(pyridinyl-N-oxide)urea plant regulators
|
|
US4672066A
(en)
|
1985-04-22 |
1987-06-09 |
Hoffmann-La Roche Inc. |
Derivatives of 4-acetyl-3-hydroxy-2-alkyl-phenoxycarboxylic acids
|
|
GB9027023D0
(en)
|
1990-12-12 |
1991-01-30 |
Wellcome Found |
Anti-atherosclerotic aryl compounds
|
|
US5162360A
(en)
*
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
|
GB9201180D0
(en)
|
1992-01-21 |
1992-03-11 |
Glaxo Group Ltd |
Chemical compounds
|
|
US6001860A
(en)
*
|
1992-05-28 |
1999-12-14 |
Pfizer Inc. |
N-aryl and N-heteroarylurea derivatives as inhibitors of acyl coenzyme A: Cholesterol acyl transferase (ACAT)
|
|
GB9304920D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
|
EP0634402A1
(en)
|
1993-07-14 |
1995-01-18 |
Takeda Chemical Industries, Ltd. |
Isochinolinone derivatives, their production and use
|
|
US5547966A
(en)
*
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
|
CA2200981A1
(en)
|
1994-10-04 |
1996-04-11 |
Hisashi Takasugi |
Urea derivatives and their use as acat-inhibitors
|
|
EP0807105B1
(en)
|
1994-10-27 |
2004-06-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists
|
|
US6010026A
(en)
|
1994-11-22 |
2000-01-04 |
Aluminum Company Of America |
Assembly of aluminum can and threaded sleeve
|
|
US5556969A
(en)
|
1994-12-07 |
1996-09-17 |
Merck Sharp & Dohme Ltd. |
Benzodiazepine derivatives
|
|
US5624937A
(en)
*
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
|
GB9504361D0
(en)
*
|
1995-03-04 |
1995-04-26 |
Glaxo Spa |
Heterocyclic compounds
|
|
GB9511355D0
(en)
|
1995-06-06 |
1995-08-02 |
Fujisawa Pharmaceutical Co |
Urea derivatives
|
|
US5972975A
(en)
*
|
1995-12-08 |
1999-10-26 |
Merck & Co., Inc. |
Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
|
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
ES2186907T3
(es)
|
1996-07-23 |
2003-05-16 |
Neurogen Corp |
Ciertos derivados de bencilamina sustituidos; una nueva clase de ligandos especificos del neuropeptido y1.
|
|
US6174905B1
(en)
*
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
AUPO390996A0
(en)
|
1996-11-29 |
1996-12-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives
|
|
JP2002241368A
(ja)
|
1997-02-18 |
2002-08-28 |
Shionogi & Co Ltd |
新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
|
|
WO1998041510A1
(en)
|
1997-03-14 |
1998-09-24 |
Shionogi & Co., Ltd. |
Novel benzolactam derivatives and medicinal compositions comprising the same
|
|
AU7526798A
(en)
|
1997-04-18 |
1998-11-27 |
Smithkline Beecham Plc |
Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders
|
|
DE69826695T2
(de)
|
1997-05-23 |
2006-02-02 |
Bayer Pharmaceuticals Corp., West Haven |
Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
|
|
EP0986382B1
(en)
|
1997-05-23 |
2008-06-25 |
Bayer Pharmaceuticals Corporation |
Raf kinase inhibitors
|
|
AU9188698A
(en)
*
|
1997-11-05 |
1999-05-24 |
Choongwae Pharma Corporation |
Novel genipin derivative having liver protection activity
|
|
AU739642B2
(en)
|
1997-12-22 |
2001-10-18 |
Bayer Healthcare Llc |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
|
EP1042305B1
(en)
|
1997-12-22 |
2005-06-08 |
Bayer Pharmaceuticals Corp. |
INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
|
|
DE1049664T1
(de)
|
1997-12-22 |
2001-05-03 |
Bayer Corp., Pittsburgh |
Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
|
|
CN100360507C
(zh)
|
1997-12-22 |
2008-01-09 |
拜尔有限公司 |
用取代杂环脲抑制raf激酶
|
|
JP4405602B2
(ja)
|
1998-04-16 |
2010-01-27 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
ヒストン脱アセチル化酵素阻害剤
|
|
CN1311773A
(zh)
|
1998-06-08 |
2001-09-05 |
先灵公司 |
神经肽y5受体拮抗剂
|
|
US6329395B1
(en)
*
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
|
US6407124B1
(en)
|
1998-06-18 |
2002-06-18 |
Bristol-Myers Squibb Company |
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
|
|
US6420381B1
(en)
|
1998-08-11 |
2002-07-16 |
Sumitomo Pharmaceuticals Company, Limited |
Naphthyridine derivatives
|
|
JP2000256194A
(ja)
|
1999-01-06 |
2000-09-19 |
Mitsui Chemicals Inc |
核内レセプタ作動薬およびその効果増強剤
|
|
US7928239B2
(en)
*
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
ES2384160T3
(es)
|
1999-01-13 |
2012-07-02 |
Bayer Healthcare Llc |
Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38
|
|
WO2000052004A1
(en)
|
1999-03-01 |
2000-09-08 |
The Regents Of The University Of California |
Thiacrown polymers for removal of mercury from waste streams
|
|
DE19921498A1
(de)
*
|
1999-05-08 |
2000-11-16 |
Clariant Gmbh |
Verfahren zur Herstellung von wäßrigen Diazoniumsalzlösungen
|
|
ATE312823T1
(de)
|
1999-07-09 |
2005-12-15 |
Boehringer Ingelheim Pharma |
Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
|
|
EP1557168B1
(en)
|
1999-07-26 |
2011-11-16 |
Msd K.K. |
Biarylurea Derivatives
|
|
CA2385972A1
(en)
|
1999-10-01 |
2001-04-12 |
Haruhisa Ogita |
Novel diarylamide derivatives and use thereof as medicines
|
|
US6492393B1
(en)
|
1999-11-16 |
2002-12-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
AU2001271357A1
(en)
|
2000-06-21 |
2002-01-02 |
Dupont Pharmaceuticals Company |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
GB0015601D0
(en)
|
2000-06-26 |
2000-08-16 |
Ferring Bv |
Novel antidiuretic agents
|
|
GB0015904D0
(en)
|
2000-06-28 |
2000-08-23 |
Hoffmann La Roche |
Inhibitors of HPV E1 helicase enzyme
|
|
ES2291329T3
(es)
|
2000-07-18 |
2008-03-01 |
Dainippon Sumitomo Pharma Co., Ltd. |
Inhibidores de la recaptacion de serotonina.
|
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
|
US6645990B2
(en)
*
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
|
US6573264B1
(en)
|
2000-10-23 |
2003-06-03 |
Cv Therapeutics, Inc. |
Heteroaryl alkyl piperazine derivatives
|
|
US7091353B2
(en)
|
2000-12-27 |
2006-08-15 |
Celgene Corporation |
Isoindole-imide compounds, compositions, and uses thereof
|
|
US20030045552A1
(en)
|
2000-12-27 |
2003-03-06 |
Robarge Michael J. |
Isoindole-imide compounds, compositions, and uses thereof
|
|
CA2435829A1
(en)
*
|
2001-01-25 |
2002-08-01 |
Guilford Pharmaceuticals Inc. |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
|
JP2002220338A
(ja)
|
2001-01-26 |
2002-08-09 |
Banyu Pharmaceut Co Ltd |
ビアリールウレア化合物又はその塩を有効成分として含有するＣｄｋ４及び／又はＣｄｋ６阻害剤
|
|
GB0117950D0
(en)
|
2001-02-16 |
2001-09-19 |
Aventis Pharma Inc |
Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
|
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
|
CA2443950C
(en)
|
2001-04-20 |
2011-10-18 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
CA2445003A1
(en)
*
|
2001-05-16 |
2002-11-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Diarylurea derivatives useful as anti-inflammatory agents
|
|
JP2004531571A
(ja)
|
2001-05-25 |
2004-10-14 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
サイトカイン生産のインヒビターとしてのカルバメート及びオキサミド化合物
|
|
WO2002099388A2
(en)
|
2001-06-07 |
2002-12-12 |
Merck & Co., Inc. |
Benzodiazepine bradykinin antagonists
|
|
DE60219793T2
(de)
*
|
2001-07-11 |
2008-01-24 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Verfahren zur Behandlung von Cytokin-Vermittelten Erkrankungen
|
|
DE10134482A1
(de)
|
2001-07-16 |
2003-01-30 |
Bayer Ag |
Substituierte Isoindole und ihre Verwendung
|
|
AUPR688101A0
(en)
|
2001-08-08 |
2001-08-30 |
Luminis Pty Limited |
Protein domains and their ligands
|
|
WO2003022820A1
(en)
|
2001-09-06 |
2003-03-20 |
Bristol-Myers Squibb Pharma Company. |
Heteroaromatic substituted cyclopropane as corticotropin releasing hormone
|
|
WO2003024933A1
(en)
|
2001-09-12 |
2003-03-27 |
Kaken Pharmaceutical Co., Ltd. |
2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
|
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
|
EP1503986B1
(en)
|
2001-12-21 |
2015-09-30 |
Cytokinetics, Inc. |
Compositions and methods for treating heart failure
|
|
US20030207872A1
(en)
*
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
WO2003062224A1
(en)
|
2002-01-17 |
2003-07-31 |
Eli Lilly And Company |
Aza-cyclic compounds as modulators of acetylcholine receptors
|
|
EP1472248A1
(en)
|
2002-01-17 |
2004-11-03 |
Eli Lilly And Company |
Modulators of acetylcholine receptors
|
|
EP1478358B1
(en)
*
|
2002-02-11 |
2013-07-03 |
Bayer HealthCare LLC |
Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
|
|
DE10208986A1
(de)
|
2002-02-28 |
2003-09-11 |
Aventis Pharma Gmbh |
Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase
|
|
WO2003074501A1
(en)
|
2002-03-07 |
2003-09-12 |
Sds Biotech K.K. |
Substituted isoxazole alkylamine derivative and agri- and horticultural fungicide
|
|
DE60335175D1
(de)
|
2002-03-28 |
2011-01-13 |
Merck Serono Sa |
Thiazolidin-carbonsäureamid-derivate als modulatoren des prostaglandin-f-rezeptors
|
|
TW200400035A
(en)
|
2002-03-28 |
2004-01-01 |
Glaxo Group Ltd |
Novel compounds
|
|
JPWO2003082808A1
(ja)
|
2002-04-03 |
2005-08-04 |
住友製薬株式会社 |
ベンズアミド誘導体
|
|
US7105505B2
(en)
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
|
WO2003088967A1
(en)
|
2002-04-18 |
2003-10-30 |
Schering Corporation |
(1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
|
|
DE60325469D1
(de)
|
2002-04-23 |
2009-02-05 |
Bristol Myers Squibb Co |
Als kinase inhibitoren geeignete arylketonpyrrolotriazin-verbindungen
|
|
US20030236287A1
(en)
|
2002-05-03 |
2003-12-25 |
Piotrowski David W. |
Positive allosteric modulators of the nicotinic acetylcholine receptor
|
|
EP1506158A2
(en)
|
2002-05-17 |
2005-02-16 |
Lica Pharmaceuticals A/S |
Diamino-functional chalcones
|
|
US6693576B2
(en)
*
|
2002-05-23 |
2004-02-17 |
Tektronix, Inc. |
Methods and apparatus providing multiple concurrent acquisition modes in a digitizing measurement instrument
|
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
|
EP1539742B1
(en)
|
2002-06-24 |
2006-11-08 |
Schering Corporation |
Indole derivatives useful as histamine h3 antagonists
|
|
KR101116627B1
(ko)
|
2002-06-27 |
2012-10-09 |
노보 노르디스크 에이/에스 |
치료제로서 아릴 카르보닐 유도체
|
|
CA2493026C
(en)
|
2002-07-31 |
2011-05-24 |
Schering Aktiengesellschaft |
Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridines
|
|
GB0218147D0
(en)
|
2002-08-05 |
2002-09-11 |
Oxford Glycosciences Uk Ltd |
Novel compounds
|
|
JP4606876B2
(ja)
|
2002-08-27 |
2011-01-05 |
キッセイ薬品工業株式会社 |
ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
|
|
CA2497440C
(en)
|
2002-09-04 |
2011-03-22 |
Schering Corporation |
Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
|
|
MXPA05002621A
(es)
|
2002-09-10 |
2005-05-05 |
Pfizer Prod Inc |
Compuestos diazabiciclos utiles en el tratamiento de transtornos del sistema nervioso central y otros trastornos.
|
|
EP1558203B1
(fr)
|
2002-10-29 |
2007-05-09 |
L'oreal |
Composition capillaire contenant un compose styryl-pyrazole
|
|
KR20050100615A
(ko)
*
|
2003-01-14 |
2005-10-19 |
싸이토키네틱스, 인코포레이티드 |
화합물, 조성물 및 방법
|
|
US7557129B2
(en)
*
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
AU2003902073A0
(en)
|
2003-05-01 |
2003-05-15 |
Kevin Raymond Deguara |
A lighting substrate
|
|
ATE462432T1
(de)
|
2003-05-05 |
2010-04-15 |
Probiodrug Ag |
Glutaminylcyclase-hemmer
|
|
JPWO2004101529A1
(ja)
|
2003-05-19 |
2006-07-13 |
小野薬品工業株式会社 |
含窒素複素環化合物およびその医薬用途
|
|
DK1626714T3
(da)
*
|
2003-05-20 |
2007-10-15 |
Bayer Pharmaceuticals Corp |
Dirarylurinstoffer mod sygdomme medieret af PDGFR
|
|
US7235353B2
(en)
|
2003-07-18 |
2007-06-26 |
Cytokinetics, Inc. |
Predicting hepatotoxicity using cell based assays
|
|
TW200529849A
(en)
*
|
2003-11-28 |
2005-09-16 |
Novartis Ag |
Diaryl urea derivatives in the treatment of protein kinase dependent diseases
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
ES2505090T3
(es)
|
2004-05-07 |
2014-10-09 |
Amgen Inc. |
Derivados heterocíclicos nitrogenados como moduladores de proteína cinasas y su uso para el tratamiento de angiogénesis y cáncer
|
|
CA2570999C
(en)
*
|
2004-06-17 |
2014-01-07 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
US7176222B2
(en)
*
|
2004-07-27 |
2007-02-13 |
Cytokinetics, Inc. |
Syntheses of ureas
|
|
WO2006089871A2
(en)
*
|
2005-02-23 |
2006-08-31 |
Neurosearch A/S |
Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
|
|
US7538223B2
(en)
*
|
2005-08-04 |
2009-05-26 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
US20070208000A1
(en)
|
2005-12-15 |
2007-09-06 |
Morgan Bradley P |
Certain chemical entities, compositions and methods
|
|
US7825120B2
(en)
|
2005-12-15 |
2010-11-02 |
Cytokinetics, Inc. |
Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
|
|
TW200808321A
(en)
|
2005-12-15 |
2008-02-16 |
Cytokinetics Inc |
Certain chemical entities, compositions and methods
|
|
US20070197505A1
(en)
*
|
2005-12-15 |
2007-08-23 |
Morgan Bradley P |
Certain chemical entities, compositions and methods
|
|
EP1959962A2
(en)
|
2005-12-16 |
2008-08-27 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
US7989455B2
(en)
*
|
2005-12-19 |
2011-08-02 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
US7672247B2
(en)
*
|
2006-02-23 |
2010-03-02 |
International Business Machines Corporation |
Evaluating data processing system health using an I/O device
|